Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune skin disorders are caused by genetic and environmental factors and are treated with various medications and preventative strategies.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Skin and mucous symptoms are key for diagnosing autoimmune connective tissue diseases.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Dandruff involves inflammation and increased skin cell growth, not just flaking.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Inflammation, possibly triggered by a specific bacteria and activated by UV radiation, may contribute to male pattern baldness.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Different autoantibody groups in pediatric SLE are linked to specific symptoms and disease outcomes.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Acne and hidradenitis suppurativa have different causes and risk factors, but both are driven by inflammation and may benefit from treatments targeting interleukin-1.

Mechanical stress may cause lesions in Hidradenitis suppurativa.

Co-trimoxazole may help treat autoimmune diseases.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Severe acne patients have higher inflammatory markers than healthy people.

ILC1-like cells may contribute to hair loss in alopecia areata.

Insulin resistance significantly contributes to the development and severity of certain chronic skin diseases.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.